The total return over the past 12 months is +8.09% vs. +23.09% for the S&P 500. So far it's up +8.42% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +6.98% | (8.30%) | (8.25%) | (2.63%) | +3.75% | +2.17% |
| Total Return CAGR | +8.09% | (7.45%) | (7.45%) | (1.82%) | +4.61% | +2.80% |
| Revenue CAGR | +9.23% | +5.76% | +4.21% | +2.20% | +4.62% | +4.76% |
| Net Income CAGR | (16.65%) | +19.18% | +6.05% | +24.60% | +1.60% | (0.02%) |
| EPS CAGR | (14.57%) | (14.84%) | N/A | +29.42% | (0.93%) | +0.93% |
| Free Cash Flow CAGR | +36.08% | +17.10% | +15.41% | +8.73% | +5.42% | +4.05% |
| Operating Cash Flow CAGR | +1.16% | +7.28% | +10.85% | +5.39% | +2.74% | +2.99% |
| Dividends CAGR | 0.00% | +0.24% | +0.59% | +1.17% | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Zimmer Biomet Holdings, Inc. (ZBH)
| Year | Start price | End price | ZBH Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $89.92 | $96.98 | +8.42% | +11.70% | (3.28%) |
| 2025 | $105.63 | $89.92 | (14.03%) | +17.72% | (31.75%) |
| 2024 | $121.70 | $105.63 | (12.46%) | +24.89% | (37.35%) |
| 2023 | $127.50 | $121.70 | (3.81%) | +26.19% | (30.00%) |
| 2022 | $123.24 | $127.50 | +4.31% | (18.17%) | +22.48% |
| 2021 | $149.49 | $123.24 | (17.03%) | +28.74% | (45.77%) |
| 2020 | $145.21 | $149.49 | +3.76% | +18.37% | (14.61%) |
| 2019 | $100.62 | $145.21 | +45.38% | +31.22% | +14.16% |
| 2018 | $117.06 | $100.62 | (13.30%) | (4.56%) | (8.74%) |
| 2017 | $100.12 | $117.06 | +17.85% | +21.70% | (3.85%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
